UTI - Healthcare Fund

UTI Mutual FundThematicPortfolio as of 31 July 2026

UTI - Healthcare Fund holds 46 instruments (96.15% equity), led by Sun Pharmaceutical Industries Limited (8.71%), Divi's Laboratories Limited (5.57%) and Ajanta Pharma Limited (4.8%), as of its 31 July 2026 SEBI-mandated monthly disclosure.

Holdings
46
Equity Allocation
96.15%
AMC
UTI Mutual Fund
Category
Thematic

This page shows the complete disclosed portfolio of UTI - Healthcare Fund, managed by UTI Mutual Fund, based on its monthly portfolio disclosure dated 31 July 2026. The fund holds 46 instruments with an equity allocation of 96.15%. Percentages are of net assets (% to NAV). Click any stock to see every other mutual fund that also holds it.

Portfolio Analysis

UTI - Healthcare Fund's top 10 holdings account for 42.65% of its portfolio, more diversified than the Thematic category average of 50.4%. Healthcare is its largest sector exposure at 92.46% of net assets, spread across 2 sectors in total. Since its 30 June 2026 disclosure, the fund added 2 new positions and exited 1 position, with Biocon Limited seeing the largest move (+0.91pp to 1.55%).

Top 10 Equity Holdings

What Changed: June 2026 → July 2026

Equity holdings compared between the fund's two latest monthly disclosures. Weights are % to NAV; weight moves can also reflect price changes, not only buying or selling.

2 new entries1 exit6 increased9 reduced

New Entries

Complete Exits

Jupiter Life Line Hospitals Limited · was 1.96%

Biggest Weight Increases

StockWeightChange
Biocon Limited0.64% → 1.55%▲ +0.91
Divi's Laboratories Limited4.74% → 5.57%▲ +0.83
Dr. Lal Path Labs Ltd.1.26% → 1.67%▲ +0.41
Rainbow Childrens Medicare Limited2.06% → 2.34%▲ +0.28
Global Health Limited2.61% → 2.81%▲ +0.2
Sun Pharmaceutical Industries Limited8.54% → 8.71%▲ +0.17

Biggest Weight Reductions

StockWeightChange
Gland Pharma Limited4.11% → 3.56%▼ -0.55
Fortis Healthcare Limited2.93% → 2.58%▼ -0.35
Viyash Scientific Limited2.32% → 1.98%▼ -0.34
Ajanta Pharma Limited5.08% → 4.8%▼ -0.28
Cohance Lifesciences Limited2.44% → 2.17%▼ -0.27
Max Healthcare Institute Limited2.98% → 2.76%▼ -0.22
Lupin Limited3.77% → 3.59%▼ -0.18
Eris Lifesciences Limited1.48% → 1.33%▼ -0.15
Alembic Pharmaceuticals Limited1.26% → 1.16%▼ -0.1

Top Holdings — Weight Trend

% to NAV of the fund's current top holdings over its last 6 monthly disclosures (Feb – Jul 2026).

Feb: 9.42%, Mar: 9.99%, Apr: 9.49%, May: 8.87%, Jun: 8.54%, Jul: 8.71%
8.71%
Feb: 3.52%, Mar: 3.42%, Apr: 3.45%, May: 4.87%, Jun: 4.74%, Jul: 5.57%
5.57%
Feb: 7.04%, Mar: 6.4%, Apr: 5.84%, May: 4.7%, Jun: 5.08%, Jul: 4.8%
4.8%
Feb: 2.23%, Mar: 2.07%, Apr: 2.17%, May: 3.08%, Jun: 4.02%, Jul: 3.95%
3.95%
Feb: 5.79%, Mar: 5.92%, Apr: 4.23%, May: 3.8%, Jun: 3.77%, Jul: 3.59%
3.59%

Full Portfolio (46 holdings)

#HoldingSector% to NAV
1Sun Pharmaceutical Industries LimitedHealthcare8.71%
2Divi's Laboratories LimitedHealthcare5.57%
3Ajanta Pharma LimitedHealthcare4.8%
4Caplin Point Laboratories LimitedHealthcare3.95%
5Lupin LimitedHealthcare3.59%
6Gland Pharma LimitedHealthcare3.56%
7Apollo Hospitals Enterprise LimitedHealthcare3.46%
8Dr. Reddy's Laboratories LimitedHealthcare3.1%
9Alkem Laboratories LimitedHealthcare3.1%
10Net Current Assetsother2.9%
11Global Health LimitedHealthcare2.81%
12Max Healthcare Institute LimitedHealthcare2.76%
13IPCA Laboratories LimitedHealthcare2.68%
14Fortis Healthcare LimitedHealthcare2.58%
15Anthem Biosciences LimitedHealthcare2.5%
16Procter & Gamble Health LimitedHealthcare2.41%
17Rainbow Childrens Medicare LimitedHealthcare2.34%
18Sai Life Sciences LimitedHealthcare2.2%
19JUPITER LIFE LINE HOSPITALSHealthcare2.18%
20Cohance Lifesciences LimitedHealthcare2.17%
21Marksans Pharma LimitedHealthcare2.17%
22Glenmark Pharmaceuticals LimitedHealthcare2.11%
23Viyash Scientific Limited1.98%
24Aster DM Healthcare LimitedHealthcare1.94%
25Aurobindo Pharma LimitedHealthcare1.84%
26Sudeep Pharma LimitedMaterials1.71%
27Dr. Lal Path Labs Ltd.Healthcare1.67%
28Metropolis Healthcare LimitedHealthcare1.64%
29Cipla LimitedHealthcare1.61%
30Biocon LimitedHealthcare1.55%
31Eris Lifesciences LimitedHealthcare1.33%
32Vijaya Diagnostic Centre LimitedHealthcare1.3%
33Pfizer LimitedHealthcare1.21%
34Windlas Biotech LimitedHealthcare1.17%
35Alembic Pharmaceuticals LimitedHealthcare1.16%
36Blue Jet Healthcare LimitedHealthcare1.13%
37Laxmi Dental LimitedHealthcare1.02%
38Emcure Pharmaceuticals LimitedHealthcare0.99%
39MANIPAL HEALTH ENTERPRISES LIMITEDother0.91%
40Sanofi Consumer Healthcare India LimitedHealthcare0.81%
41Krishna Institute of Medical Sciences LimitedHealthcare0.81%
42Aarti Pharmalabs LimitedHealthcare0.73%
43Orchid Pharma LimitedHealthcare0.73%
44Jubilant Pharmova LimitedHealthcare0.61%
45Syngene International LimitedHealthcare0.46%
46CLEARING CORPORATION OF INDIA LTD. STD - MARGINother0.02%

Frequently Asked Questions

Yes. As of its 31 July 2026 disclosure, Sun Pharmaceutical Industries Limited is 8.71% of UTI - Healthcare Fund's net assets — its number 1 holding.
Yes. As of its 31 July 2026 disclosure, Divi's Laboratories Limited is 5.57% of UTI - Healthcare Fund's net assets — its number 2 holding.
Yes. As of its 31 July 2026 disclosure, Ajanta Pharma Limited is 4.8% of UTI - Healthcare Fund's net assets — its number 3 holding.
Yes. As of its 31 July 2026 disclosure, Caplin Point Laboratories Limited is 3.95% of UTI - Healthcare Fund's net assets — its number 4 holding.
Yes. As of its 31 July 2026 disclosure, Lupin Limited is 3.59% of UTI - Healthcare Fund's net assets — its number 5 holding.

New to reading these? See How to Read a Mutual Fund's Monthly Portfolio Disclosure, or check terms like % to NAV in the glossary.

Source: UTI Mutual Fund's SEBI-mandated monthly portfolio disclosure, dated 31 July 2026. Data is for information only, not investment advice. Holdings may have changed since the disclosure date.